Abstract
BACKGROUND:
Peripheral nerve damage mainly resulted from traumatic or infectious causes; the main signs of a damaged nerve are the loss of sensory and/or motor functions. The injured nerve has limited regenerative capacity and is recovered by the body itself, the recovery process depends on the severity of damage to the nerve, nowadays the use of stem cells is one of the new and advanced methods for treatment of these problems.
METHOD:
Following our review, data are collected from different databases "Google scholar, Springer, Elsevier, Egyptian Knowledge Bank, and PubMed" using different keywords such as Peripheral nerve damage, Radial Nerve, Sciatic Nerve, Animals, Nerve regeneration, and Stem cell to investigate the different methods taken in consideration for regeneration of PNI.
RESULT:
This review contains tables illustrating all forms and types of regenerative medicine used in treatment of peripheral nerve injuries (PNI) including different types of stem cells " adipose-derived stem cells, bone marrow stem cells, Human umbilical cord stem cells, embryonic stem cells" and their effect on re-constitution and functional recovery of the damaged nerve which evaluated by physical, histological, Immuno-histochemical, biochemical evaluation, and the review illuminated the best regenerative strategies help in rapid peripheral nerve regeneration in different animal models included horse, dog, cat, sheep, monkey, pig, mice and rat.
CONCLUSION:
Old surgical attempts such as neurorrhaphy, autogenic nerve transplantation, and Schwann cell implantation have a limited power of recovery in cases of large nerve defects. Stem cell therapy including mesenchymal stromal cells has a high potential differentiation capacity to renew and form a new nerve and also restore its function.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
1 Introduction
Traumatic affections of peripheral nerves were the most common serious problems leading to a long-lasting disability including sensory and motor dysfunction, neuropathic pain, muscle atrophy, and even limitation of life [1]. Sciatic, peroneal, tibia, brachial plexus, and radial nerves were the most commonly affected peripheral nerves [2].
The radial nerve is the largest nerve of the brachial plexus supplying all extensors of carpal and digit and even sensation of dorsal region of carpus and digit, its injury occurs as a result of drag, transaction, pressurization, vehicle accident that leads to a complete humeral fracture and also local injections of some drugs [3].
Sciatic nerve is the thickest nerve in the whole body and it is considered the main direct continuation of lumbosacral plexus, descending as distal as the heel of the foot, supplies several muscles in the leg and even sensation of most skin of the lower leg [4–6]. Sciatic injuries were commonly caused by compression, stretching or traction, laceration, crushing, and also pelvic fracture [1].
Central nervous system (CNS) has no tendency to heal, while peripheral nerve repair is limited, and complete recovery doesn't occur in most critical conditions. Repairing mechanism is a complex of several pathological interactions such as neuronal and axonal regeneration, Wallerian degeneration, production of inflammatory cytokines, and neurotrophic factors from Schwan cells [7].
Traditionally, Peripheral nerve injuries (PNI) have been managed surgically either by end-to-end or end-to-site anastomosis. Nerve auto-grafting in long nerve defects was considered the gold standard for management of PNI but has some restrictions for obtaining donor nerve, donor –nerve infection, and neuroma formation [4]. Schwan cell auto transplantation has two major disadvantages including a long time for in vitro growth and culture and also the additional damage to donors [8].
Besides the disadvantages of the previous traditional methods, they don't achieve full nerve recovery and a satisfactory result has not been obtained. Nowadays, medicine is directed to tissue engineering to solve most regardless cases of nerve dysfunction, organ failure, and end-stage disease [7]. Transplantation of allogenic Schwan cells together with a nerve scaffold helps in provoking therapeutic nerve repair and become an applicable method in human cases [4].
Mesenchymal stem cells (MSCS) are multi-potent, plastic, un-differentiated cells that can be obtained from several body sources such as bone marrow, adipose tissue, amniotic membrane, dental pulp, and umbilical cord [9]. MSCS transplantation has proved a successful progress in repairing most damaged tissues and this capacity came from their self-renewal, fast-proliferation, and multi-potent differentiation [8]. Bone marrow mesenchymal stem cells (BMSCS) promote nerve repair through synthesis of neurotrophic factors such as" nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin 3 (NTF3), and glial cell-derived neurotrophic factor (GDNF) ". The BMSCS isolation is considered an invasive technique with a low number of harvested cells to enhance proliferation and differentiation [8]. So, trials are directed toward adipose-derived stem cells which have the same phenotype and genotype regeneration power as BMSCS but rejoice by other features as it can be easily obtained from any fat-rich source, its low immunogenicity, and its faster proliferation than BMSCS [10].
Nerve guidance conduits are tubular structures that can be used for bridging and regeneration of nerve gap defects when injected with extracellular matrix proteins (ECM), growth factors, or supporting cells when autografting is limited due to donor availability [11,12,13]. There were different kinds of artificial nerve conduits such as chitosan, collagen, and poly (DL-lactide-ε-caprolactone) and they are considered the most commonly and frequently used in research studies [14, 15].
The properties of the ideal nerve conduits were good biodegradability and biocompatibility within the tissue, better porosity and permeability for drug release, and low immunogenicity and toxicity for the body. These characteristics facilitate neural regeneration and stimulate axonal remyelination at the site of injury [16, 17]. In our review, we demonstrate various nerve conduits used for the repair of nerve injury and the potential effect of each type in peripheral nerve regeneration.
ADSCs are pluripotent adult stem cells, obtained from any fat-rich sources that had the properties of rapid proliferation and multi-lineage differentiation into osteoblasts, chondrocytes, and adipocytes as BMSCs, but it differs in their higher intensity in fatty tissue after isolation, so it takes a shorter period for tissue regeneration than BMSCs. ADSCs have low immunogenicity power and are rarely rejected by the recipients [8, 18, 19].
BMSCs are another multipotent adult mesenchymal stem cells that can be easily obtained through aspiration of bone marrow. They can differentiate into bone, cartilage, and fat cells and present neural or glial markers typical of Schwann cells in several neurodegenerative diseases. However, they have low proliferation power than embryonic stem cells and a more invasive method than ADSCs as they require anesthesia in addition to their low cell count after isolation regarding other types of stem cells [20,21,22].
EPCs (Endothelial progenitor cells or umbilical cord mesenchymal stem cells) are proliferative cells produced from fetal tissue after birth with no invasive procedure to the donor or patient and are also available in cell banks. They can be easily and ethically obtained compared with embryonic or bone marrow stem cells, so they are usually preferred over other types. The proliferation capacity and differentiation power of umbilical cord mesenchymal stem cells are proved to be higher when compared with bone marrow mesenchymal stem cells [18, 23, 24].
2 Material and method
Our review collected from different databases focusing on research investigating the different treatment strategies of peripheral nerve injuries including therapeutic medicines, nerve conduits, and different types of stem cells in different animal models (rat, mice, rabbit, cat, dog, monkey, pig and sheep hoping that these trials can be used as an "off-shelf" medicine in human and animal application.
3 Result
3.1 Peripheral nerve injury (PNI)
Stretch-related injuries are the most common and frequent type of PNI, and their etiology is usually inherited where the nerve nature is very elastic due to its collagenous endoneurium. The nerve injury occurs when it is exposed to a force exceeding its strength and when this force is high enough may result in a full disruption of nerve continuity as in brachial plexus avulsion. Stretch-related injuries occur in the case of nerves that are anatomically related to bones as radial nerve paralysis in complete humeral fracture [25].
The second common type is laceration injuries, which represent about 30% of serious cases, whereas a complete cutting of the nerve or parts from it occurs. This type is mostly involved in research because it is easier to be performed [26].
The third type of PNI is nerve compression which may be induced either by mechanical deformation or ischemia. The most severe form of this type is related to complete disruption of the action potential without any tearing or transection of nerve fibers. So, researchers confused about the pathophysiology of this type either is due to external pressure applied on the nerve or due to induced ischemia especially since there is no, or little histological evidence reported in this type. “Saturday Night palsy” due to radial nerve compression was documented and ultra-structural studies showed myelin and axoplasm dis-positioning and nerve fibers degeneration at the compression site more severe than in areas away from the compression [27].
3.2 Nerve injury classification and grading
Seddon divided nerve injuries by severity into three broad categories: neurapraxia, axonotmesis, and neurotmesis. Neurapraxia is the simplest form of injury with a mild interruption in nerve impulse conduction, but the continuity of the nerve is not affected. So, it is a transient condition with varying recovery periods. Axonotmesis means discontinuity in axon and myelin sheath with damaged endoneurium and perineurium. Neurotmesis involves disconnection of a nerve with loss of nerve function and recovery without surgical intervention does not usually occur because of scar formation and the loss of the mesenchymal guide that properly directs axonal regrowth [28].
Sunderland’s classification system further re-classifies three injury types described by Seddon into five categories depending on the severity of the damage as shown in Table 1 A first-degree injury is equivalent to Seddon’s neurapraxia, and a second-degree injury is equivalent to axonotmesis. Third-degree nerve injuries occur when there is disruption of the axon (axonotmesis with partial loss in endoneurium). Seddon’s neurotmesis represents fourth- and fifth-degree injuries in Sunderland’s classification. In a fourth-degree injury, all parts of the nerve are damaged except the epineurium. Five-degree injury is the most severe form in which there is complete dis-connection of the nerve [29].
3.3 Neuropathology and mechanism of injury
The peripheral nerve trunk is mainly composed of several nerve fascicles and is surrounded by its connective tissue sheath known as epineurium. Each fascicle consists of groupings of nerve axons entrapping within the endoneurium sheath while the nerve fascicles are surrounded by a different type of sheath called perineurium. The orientation of fibers in each sheath differs from each other, the perineurium and epineurium are circular but the endoneurium is longitudinally aligned. Many blood capillaries are distributed within the epineural sheath and give collateral minor vessels to supply the endoneurial sheath through the perineurium. This vascularization system can aid in introducing a secondary injury to the nerve when expose to severe compression leading to vascular edema causing additional pressure on the nerve structure and contribute to nerve trauma [30].
There are various mechanisms for applying pressure on the nerve and succeeding in nerve injury. Compression of vascular capillaries supplying peripheral nerve when the nerve runs through a narrow anatomical position causes ischemia to the nerve and is categorized as grade 1 injuries or neuropraxia. Traumatic compression by a blunt object as surgical forceps or clamps to an extended period without nerve cutting is usually categorized as a crush injury. Laceration by a knife, gunshot, or glass piece led to the discontinuation of the nerve known as neurotmesis [31].
Sciatic and radial nerve damage may be occurred after intra-muscular injection due to the harmful effect of the injected drug, or the physical trauma caused by in correct method of injection by a less experienced person resulting in sever trouble shock in sensation and may extend to a motor dysfunction [32].
3.4 Neural response to injury
A series of degenerative cascades occur after nerve injury which is considered a direct precursor to regeneration. The extent of regeneration is primarily influenced by the degree of initial damage and subsequent degenerative changes. In first-degree, there is only a conduction block and no true degeneration or regeneration; pathological changes are mild or nonexistent. In the second degree, a calcium-mediated process known as Wallerian (or anterograde) degeneration occurs distal to the injury site with little histological change at the injury site or nearby [33].
In third-degree injuries (intra fascicular injuries), a significant trauma-induced local reaction displaces. The elastic endoneurium retracts the ends of severed nerve fiber. Hemorrhage and edema from local vascular trauma cause a strong inflammatory response. The injured segment develops a dense fibrous scar as fibroblasts multiply, which results in fusiform swelling (neuroma) and additional perineural scar tissue [25].
3.5 Treatment strategies involved in PNI
In recent years, most candidates are directed to advanced alternative medicines in manipulation of PNI cases instead of previous old surgical interventions like end-to-end anastomosis, donor nerve transplantation, allografting of various types of nerve grafts like vein allograft, and implantation of Schwann cell in the injury site. The recent treatment strategies included different types of stem cells and nerve conduits.
3.5.1 Adipose-derived stem cells (ADSCs)
The ADSCs can be easily harvested from any fat tissue source with no harmful effect and resulted in a high number of cells with very fast culturing and harvesting techniques. It has a good restoration of functional assessment of nerve physiology [34].
3.5.2 Bone marrow stem cells (BMSCs)
Mesenchymal stem cells (MSCs), in particular BMSCs, have been demonstrated to be the greatest candidate for regenerating neural tissues. They could rapidly transform into axons and Schwann cells with little immunogenicity and effective immune regulation. They are extremely proliferative and can change into multiple tissue lineages [35].
3.5.3 Umbilical cord stem cells (Endothelial progenitor cells)
Schwann cells, brain cells, and axons can all be produced by umbilical cord stem cells (hematopoietic stem cells). Their results are quite encouraging, and positive outcomes have been noted but it needs tissue banks [36].
3.5.4 Nerve conduits
A nerve guidance conduit (artificial nerve conduit or artificial nerve graft) is an artificial means of guiding axonal regrowth to facilitate nerve regeneration and it's one of several clinical treatments for nerve injuries. Examples: Collagen nerve conduit, silicone tube, chitosan/fibroin-based nerve scaffold, polycaprolactone nerve conduit (PCL), Silk fibroin -based nerve graft, and polyglycolic acid (PGA) conduit. Using stem cells alone without a guiding material as a nerve graft conduit does not aid in bridging the nerve to re-construct again so most recent research are used these innovative alternatives as a promising guide for cell transplantation [37].
3.5.5 Current progress strategies
Recently, miscellaneous types of stem cells and growth factors have been used to produce efficient results in a limited time either alone or with different types of conduits together. Olfactory ensheathing cells (OECs), Autologous dermal fibroblasts, neural stem cells (NCS), Gingival derived mesenchymal stem cells (GMSCs), basic fibroblast growth factor (bFGF), glial cell line-derived neurotrophic factor (GDNF) and gene transfer of adenoviral bone morphogenetic proteins (AdBMP7) have been conducted in recent studies [18, 38,39,40,41,42] (Table 2).
3.6 Animal models of PNI regeneration
Most of the candidates in research had resorted to using animal models to help in the modification of the ideal method of treatment to be applied in human therapy strategies in many urgent cases. Rodents are less similar to human immune system, while dogs, cats, swine, sheep, and non-human primates are considered the most volunteers in resembling the human body physiology and ideal to be used to obtain the best evaluation of functional recovery [62].
Concerning experimental studies using rodents as an animal model, we investigate 58 research demonstrate different treatment strategies like using adipose stem cells, bone marrow stem cells, neural crest stem cells, and other types of mesenchymal stem cells also application of various kinds of nerve conduit as ANA conduit, NeuraWrap™, fibrin gel conduit and also administration of many drugs help in improving nerve recovery as alfa-lipoic acid, curcumin, Zofenopril, dexamethasone and methyl cobalamin (MeCbl). Induction of injury is either done by crushing using surgical clump or forceps, or by a transaction of a piece of nerve and filling the gap formed in between the two stumps by conduit material. The follow-up period is differed according to many factors like weight, age, species, and also the methods of evaluation used are confined to behavioral analysis as a sciatic functional index, electrophysiological parameters, histopathological analysis, fluorogold retro-tracing assessment, electron microscope, and gene expression by real-time PCR, Figs. 1, 2 and 3 summarized the different regenerative strategies and animal models used in PNI.
In canine studies, different types of mesenchymal stem cells were used to heal the most affected nerves such as radial in the forelimb and sciatic in the hindlimb. Other methods as autografting of nerve after removal, application of nerve guidance conduit, and injection of nerve growth factors and extra-cellular vesicles are also used. Clinical evaluations were conducted by using histopathology, immunohistochemistry, and functional assessment either motor or sensory. The result was obtained by comparison to control group animals in each parameter and many studies were compared to autografting as considered the ideal technical approach in nerve quality healing.
In feline studies, only two research had reported in the peripheral nerve injury model and approach to treatment by grafting normal body tissue like venules or a synthetic sponge material had proved that nerve recovery after implantation was better unless untreated.
In pigs, rabbits, monkeys, and sheep, most of the research was found helpful in manipulation of nerve injury by using stem cell therapy together with nerve grafting after several types of nerve injuries. So, nowadays after all of these articles, there is no difficult way to apply any of these modern approaches when facing different types of nerve injuries by backing and following up the newest published articles.
3.7 Effect of animal models in the direction of research study in PNI
Regarding the animal that can be selected according to the effect of different therapeutic methods on an injured nerve, each animal has its point of selection. Murine species (rats and mice) are the most frequently used on a small animal scale, they are considered more economic, easily handled, housed, and investigated in large groups that became more accurate and representative, although, the gap applied in this species (almost not exceed 10 mm) which is relatively shorter than those of a human gap, also suspected time for complete healing is very short compared to human nerve injuries. ultrasonography required for following up the improvement cascade was almost difficult to be applied besides the genomic material of this species being lower than that of human beings [63, 64].
Canine and feline species are considered heavily weighted animals. Their weight helped in typical clinical signs of peripheral nerve injuries such as knuckling syndrome in sciatic neuropathy, so facilitate follow-up of the case and the degree of improvement. In addition, this species is relatively more similar to human genomic basis and produces more representative outcomes after a certain period of treatment. On the other hand, this species has an ethical problem with its use in research studies, they require high cost for purchase, housing, and care during the experimental period and the availability is limited in certain countries [65, 66].
Rabbits are one of the most commonly used animal models in nerve regeneration studies and their gaps are near to those that occur in humans, but they have a high cost of purchasing and housing, also they need an intense care system. Rabbits’ life is short, they rarely exceed five months, so this period is not enough for large gap studies.large animal models like pigs, sheep, equine, and non-human primates are limited in experimental studies due to their very high-cost, difficult housing, care, and, evaluation of the study, However, the absolute similarity between human and non-human primates became a promising challenge for testing the appropriate methods and efficacy of treatment strategies before applied in human being.[67,68,69].
The choice of an appropriate animal model in future research studies depends on the direction of research goals and ideas. Rats and mice will remain the most commonly used models in research studies for their advantages mentioned above, However, human injury defects can be representative by large models such as dogs and monkeys that are limited as their high-cost issues and ethical concerns. So, according to the aims of the designed study and the outcome expected to be obtained, the authors are directed to their best choice of the animal model.
3.8 Some clinical trials reported in pni using stem cell therapy
Although several research studies investigate the stem cell protocol in the treatment of animal models undergoing peripheral nerve damage, however in most vet clinic cases using these technologies remains almost rare. But there were various cases documented in human using these trials. A study was conducted by the University of Miami, Florida, United States, they used autologous human Schwan cells augmentation in several nerve injuries (ClinicalTrials.gov Identifier: NCT05541250). Another study was presented by Zhang Peixun, Department of Orthopedics and Trauma, Peking University People's Hospital, they investigate the Mid-term clinical effect of biodegradable conduit small gap tubulation to repair peripheral nerve injury in multi-center (ClinicalTrials.gov Identifier: NCT03359330).
3.8.1 Future prospectives of stem cell therapy in PNI
Several studies have proved that stem cell-based therapy has the potential to induce nerve regeneration and axonal remyelination, but they differ in their preference for which type performs the greatest and the highest efficacy. Seyed-Forootan et al., 2019 showed that ADSCs and BMSCs have the greatest power of neural regeneration among other types of stem cells and added that BMSCs are the best choice in this filed [34]. On the other hand, Dadon-Nachum et al., 2011 recommended that Stem cells obtained from bone marrow, adipose tissue, amniotic fluid, and hair follicles are the most commonly used types. Recently stem cells were used with growth factors such as PRP, glial cell line-derived neurotrophic factor, and basic fibroblast growth factor, more over medicine nowadays was directed to the use of extracellular vesicles of stem cells (exosomes) that help in providing a favorable microenvironment for peripheral nerve regeneration via mediating axonal growth and regulate inflammatory cascade after injury. Overall, we believed that stem cell therapy became an accessible routine in the treatment strategy of different kinds of PNI and is considered the better regenerative medicine for the improvement of traditional old therapeutic interventions.
4 Conclusion
Peripheral nerve injuries had a limited regeneration capacity particularly when the nerve gap exceeds the possible degree of extend, the nerve axon couldn’t be able to reconstruct a new nerve tissue so maintenance of the Peripheral nerve's proper functionality after injury becomes an intractable challenge for clinical researchers. Nowadays, most of the clinical trials involved in treatment of this PNI are directed to different types of mesenchymal stem cell therapies as an alternative to nerve neurorrhaphy to obtain high-quality healed nerve tissue. In our review, we conclude that nerve grafting applications together with stem cells alone or with other growth factors have the best scoring of nerve repairing capacity. After that, the use of nerve conduit alone came later to help Schwan cell in building of new axons and enhance the reverse of Wellerian degeneration. However, other techniques like systemic injection of therapeutic medicine such as nerve tonics and natural antioxidants gave good results in much research and opened a way to interpose in this innovated medicine (Tables 3–8).
Data availability
All data collected or analyzed during this study are included in this published review.
Abbreviations
- CNS:
-
Central nervous system
- NCS:
-
Neural stem cells
- PNI:
-
Peripheral nerve injuries
- GMSCs:
-
Gingival-derived mesenchymal stem cells
- MSCS:
-
Mesenchymal stem cells
- bFGF:
-
Basic fibroblast growth factor
- BMSCS:
-
Bone marrow mesenchymal stem cells
- GDNF:
-
Glial cell line-derived neurotrophic factor
- ADSCs:
-
Adipose-Derived Stem Cells
- NGF:
-
Nerve growth factor
- OECs:
-
Olfactory ensheathing cells
- NTF3:
-
Neurotrophin 3
- BDNF:
-
Brain-derived neurotrophic factor
- PCL:
-
Polycaprolactone nerve conduit
- GDNF:
-
Glial cell-derived neurotrophic factor
- AdBMP7:
-
Gene transfer of adenoviral bone morphogenetic proteins
- PGA:
-
Poly glycolic acid
References
Rodríguez Sánchez DN, de Lima Resende LA, Boff Araujo Pinto G, de Carvalho Bovolato AL, Possebon FS, Deffune E, et al. Canine adipose-derived mesenchymal stromal cells enhance neuroregeneration in a rat model of sciatic nerve crush injury. Cell Transpl. 2019;28:47–54.
Campbell WW. Evaluation and management of peripheral nerve injury. Clin Neurophysiol. 2008;119:1951–65.
Li Z, Qin H, Feng Z, Liu W, Zhou Y, Yang L, et al. Human umbilical cord mesenchymal stem cell-loaded amniotic membrane for the repair of radial nerve injury. Neural Regen Res. 2013;8:3441.
Chuang MH, Ho LH, Kuo TF, Sheu SY, Liu YH, Lin PC et al. Regenerative potential of platelet-rich fibrin releasate combined with adipose tissue-derived stem cells in a rat sciatic nerve injury model. Cell Transpl. 2020;29:0963689720919438.
Zack-Williams SD, Butler PE, Kalaskar DM. Current progress in use of adipose derived stem cells in peripheral nerve regeneration. World J Stem Cells. 2015;7:51.
Al-Magsoosi HH, Al-Bayati HS, Al-Timmemi HA. immuno-hematological response to radial nerve injury and human umbilical cord-mesenchymal stem cells (Huc-MSCS) therapy in dogs. IRAQ Biochem Cell Arch. 2020;20:6447–56.
Bojanic C, To K, Zhang B, Mak C, Khan WS. Human umbilical cord derived mesenchymal stem cells in peripheral nerve regeneration. World J Stem Cells. 2020;12:288.
Liu G, Cheng Y, Guo S, Feng Y, Li Q, Jia H, et al. Transplantation of adipose-derived stem cells for peripheral nerve repair. Int J Mol Med. 2011;28:565–72.
Wagner W, Wein F, Seckinger A, Frankhauser M, Wirkner U, Krause U, et al. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol. 2005;33:1402–16.
Kingham PJ, Kalbermatten DF, Mahay D, Armstrong SJ, Wiberg M, Terenghi G. Adipose-derived stem cells differentiate into a Schwann cell phenotype and promote neurite outgrowth in vitro. Exp Neurol. 2007;207:267–74.
Jahromi M, Razavi S, Bakhtiari A. The advances in nerve tissue engineering: from fabrication of nerve conduit to in vivo nerve regeneration assays. J Tissue Eng Regen Med. 2019;13:2077–100.
Nectow AR, Marra KG, Kaplan DL. Biomaterials for the development of peripheral nerve guidance conduits. Tissue Eng Part B Rev. 2012;18:40–50.
Sundback CA, Shyu JY, Wang Y, Faquin WC, Langer RS, Vacanti JP, et al. Biocompatibility analysis of poly (glycerol sebacate) as a nerve guide material. Biomaterials. 2005;26:5454–64.
Kornfeld T, Vogt PM, Radtke C. Nerve grafting for peripheral nerve injuries with extended defect sizes. Wiener Medizinische Wochenschrift (1946). 2019;169:240.
Kehoe S, Zhang X, Boyd D. FDA approved guidance conduits and wraps for peripheral nerve injury: a review of materials and efficacy. Injury. 2012;43:553–72.
De Ruiter GC, Malessy MJ, Yaszemski MJ, Windebank AJ, Spinner RJ. Designing ideal conduits for peripheral nerve repair. Neurosurg Focus. 2009;26:E5.
Inkinen S, Hakkarainen M, Albertsson A-C, Södergård rd A. From lactic acid to poly (lactic acid)(PLA): characterization and analysis of PLA and its precursors. Biomacromol. 2011;12:523–32.
Li D, Wang C, Shan W, Zeng R, Fang Y, Wang P. Human amnion tissue injected with human umbilical cord mesenchymal stem cells repairs damaged sciatic nerves in rats. Neural Regen Res. 2012;7:1771.
Georgiou M, Golding JP, Loughlin AJ, Kingham PJ, Phillips JB. Engineered neural tissue with aligned, differentiated adipose-derived stem cells promotes peripheral nerve regeneration across a critical sized defect in rat sciatic nerve. Biomaterials. 2015;37:242–51.
Xue C, Hu N, Gu Y, Yang Y, Liu Y, Liu J, et al. Joint use of a chitosan/PLGA scaffold and MSCs to bridge an extra large gap in dog sciatic nerve. Neurorehabil Neural Repair. 2012;26:96–106.
Xue C, Ren H, Zhu H, Gu X, Guo Q, Zhou Y, et al. Bone marrow mesenchymal stem cell-derived acellular matrix-coated chitosan/silk scaffolds for neural tissue regeneration. J Mater Chem B. 2017;5:1246–57.
Chen C, Tian Y, Wang J, Zhang X, Nan L, Dai P, et al. Testosterone propionate can promote effects of acellular nerve allograft-seeded bone marrow mesenchymal stem cells on repairing canine sciatic nerve. J Tissue Eng Regen Med. 2019;13:1685–701.
Matsuse D, Kitada M, Kohama M, Nishikawa K, Makinoshima H, Wakao S, et al. Human umbilical cord-derived mesenchymal stromal cells differentiate into functional Schwann cells that sustain peripheral nerve regeneration. J Neuropathol Exp Neurol. 2010;69:973–85.
Gärtner A, Pereira T, Simões MJ, Armada-da-Silva PA, França ML, Sousa R, et al. Use of hybrid chitosan membranes and human mesenchymal stem cells from the Wharton jelly of umbilical cord for promoting nerve regeneration in an axonotmesis rat model. Neural Regen Res. 2012;7:2247.
Burnett MG, Zager EL. Pathophysiology of peripheral nerve injury: a brief review. Neurosurg Focus. 2004;16. E1. https://doi.org/10.3171/foc.2004.16.5.2.
Jacques L, Kline D. Response of the peripheral nerve to physical injury. In: Crockard A, Hayward R, Hoff JT, editors. Neurosurgery: The Scientific Basis of Clinical Practice, vol. 1. London: Blackwell; 2000. p. 516–25.
Ochoa J, Fowler T, Gilliatt RW. Anatomical changes in peripheral nerves compressed by a pneumatic tourniquet. J Anat. 1972;113:433.
Seddon H. Three types of nerve injury. Brain. 1943;66:237–88.
Sunderland S. Nerves and nerve in juries. Edinburgh: E& S Livingstone Ltd; 1968.
Sunderland SS. The anatomy and physiology of nerve injury. Muscle Nerve Official J Am Assoc Electrodiagn Med. 1990;13:771–84.
Zochodne D, Levy D. Nitric oxide in damage, disease and repair of the peripheral nervous system. Cell Mol Biol (Noisy le Grand, France). 2005;51:255–67.
Seddighi A, Nikouei A, Seddighi AS, Zali AR, Tabatabaei SM, Sheykhi AR, et al. Peripheral nerve injury: a review article. Int Clin Neurosci J. 2016;3:1–6.
Waller AV. XX Experiments on the section of the glossopharyngeal and hypoglossal nerves of the frog, and observations of the alterations produced thereby in the structure of their primitive fibres. Philos Trans Royal Soc London. 1850;140:423–9.
Seyed-Forootan K, Karimi A-M, Karimi H, Jafarian A-A, Seyed-Forootan N-S, Ravari FK Nerve regeneration and stem cells. Biom J Sci Tech Res. 2019;18:13540–5.
Shi G, Hu Y. Research Progress in Seeding Cells of Peripheral Nerve. Sheng wu yi xue Gong Cheng xue za zhi J Biomed Eng Shengwu Yixue Gongchengxue Zazhi. 2015;32:470–4.
Frausin S, Viventi S, Falzacappa LV, Quattromani MJ, Leanza G, Tommasini A, et al. Wharton’s jelly derived mesenchymal stromal cells: Biological properties, induction of neuronal phenotype and current applications in neurodegeneration research. Acta Histochem. 2015;117:329–38.
Wu X, Ren J, Li J. Fibrin glue as the cell-delivery vehicle for mesenchymal stromal cells in regenerative medicine. Cytotherapy. 2012;14:555–62.
Ide C, Tohyama K, Tajima K, Endoh K-i, Sano K, Tamura M, et al. Long acellular nerve transplants for allogeneic grafting and the effects of basic fibroblast growth factor on the growth of regenerating axons in dogs: a preliminary report. Exp Neurol. 1998;154:99–112.
Tan C, Ng M, Ohnmar H, Lokanathan Y, Nur-Hidayah H, Roohi S, et al. Sciatic nerve repair with tissue engineered nerve: Olfactory ensheathing cells seeded poly (lactic-co-glygolic acid) conduit in an animal model. Ind J Orthop. 2013;47:547–52.
Jones I, Novikova LN, Novikov LN, Renardy M, Ullrich A, Wiberg M, et al. Regenerative effects of human embryonic stem cell-derived neural crest cells for treatment of peripheral nerve injury. J Tissue Eng Regen Med. 2018;12:e2099–109.
Mitsuzawa S, Ikeguchi R, Aoyama T, Takeuchi H, Yurie H, Oda H, et al. The efficacy of a scaffold-free Bio 3D conduit developed from autologous dermal fibroblasts on peripheral nerve regeneration in a canine ulnar nerve injury model: a preclinical proof-of-concept study. Cell Transplant. 2019;28:1231–41.
Zhang Q, Burrell JC, Zeng J, Motiwala FI, Shi S, Cullen DK, et al. Implantation of a nerve protector embedded with human GMSC-derived Schwann-like cells accelerates regeneration of crush-injured rat sciatic nerves. Stem Cell Res Ther. 2022;13:263.
Erb DE, Mora RJ, Bunge RP. Reinnervation of adult rat gastrocnemius muscle by embryonic motoneurons transplanted into the axotomized tibial nerve. Exp Neurol. 1993;124:372–6.
Thomas CK, Sesodia S, Erb DE, Grumbles RM. Properties of medial gastrocnemius motor units and muscle fibers reinnervated by embryonic ventral spinal cord cells. Exp Neurol. 2003;180:25–31.
MacDonald SC, Fleetwood IG, Hochman S, Dodd JG, Cheng GK, Jordan LM, et al. Functional motor neurons differentiating from mouse multipotent spinal cord precursor cells in culture and after transplantation into transected sciatic nerve. J Neurosurg. 2003;98:1094–103.
Deshpande DM, Kim YS, Martinez T, Carmen J, Dike S, Shats I, et al. Recovery from paralysis in adult rats using embryonic stem cells. Ann Neurol. 2006;60:32–44.
Craff MN, Zeballos JL, Johnson TS, Ranka MP, Howard R, Motarjem P, et al. Embryonic stem cell–derived motor neurons reserve muscle after peripheral nerve injury. Plast Reconstr Surg. 2007;119:235–45.
Dadon-Nachum M, Melamed E, Offen D. Stem cells treatment for sciatic nerve injury. Expert Opin Biol Ther. 2011;11:1591–7.
Gao J, Coggeshall RE, Chung JM, Wang J, Wu P. Functional motoneurons develop from human neural stem cell transplants in adult rats. NeuroReport. 2007;18:565–9.
Murakami T, Fujimoto Y, Yasunaga Y, Ishida O, Tanaka N, Ikuta Y, et al. Transplanted neuronal progenitor cells in a peripheral nerve gap promote nerve repair. Brain Res. 2003;974:17–24.
Wakao S, Matsuse D, Dezawa M. Mesenchymal stem cells as a source of Schwann cells: their anticipated use in peripheral nerve regeneration. Cells Tissues Organs. 2014;200:31–41.
Santiago LY, Clavijo-Alvarez J, Brayfield C, Rubin JP, Marra KG. Delivery of adipose-derived precursor cells for peripheral nerve repair. Cell Transplant. 2009;18:145–58.
Erba P, Mantovani C, Kalbermatten DF, Pierer G, Terenghi G, Kingham PJ. Regeneration potential and survival of transplanted undifferentiated adipose tissue-derived stem cells in peripheral nerve conduits. J Plast Reconstr Aesthet Surg. 2010;63:e811–7.
di Summa PG, Kingham PJ, Raffoul W, Wiberg M, Terenghi G, Kalbermatten DF. Adipose-derived stem cells enhance peripheral nerve regeneration. J Plast Reconstr Aesthet Surg. 2010;63:1544–52.
Passier R, Mummery C. Origin and use of embryonic and adult stem cells in differentiation and tissue repair. Cardiovasc Res. 2003;58:324–35.
Him A, Onger M, Delibas B. Peripheral nerve regeneration and stem cell therapies. Sakarya Tıp Dergisi. 2018;8:182–92.
Stratton JA, Shah PT, Kumar R, Stykel MG, Shapira Y, Grochmal J, et al. The immunomodulatory properties of adult skin-derived precursor S chwann cells: implications for peripheral nerve injury therapy. Eur J Neurosci. 2016;43:365–75.
Sparling JS, Bretzner F, Biernaskie J, Assinck P, Jiang Y, Arisato H, et al. Schwann cells generated from neonatal skin-derived precursors or neonatal peripheral nerve improve functional recovery after acute transplantation into the partially injured cervical spinal cord of the rat. J Neurosci. 2015;35:6714–30.
Pan HC, Cheng FC, Chen CJ, Lai SZ, Lee CW, Yang DY, et al. Post-injury regeneration in rat sciatic nerve facilitated by neurotrophic factors secreted by amniotic fluid mesenchymal stem cells. J Clin Neurosci. 2007;14:1089–98.
Pan HC, Chin CS, Yang DY, Ho SP, Chen CJ, Hwang SM, et al. Human amniotic fluid mesenchymal stem cells in combination with hyperbaric oxygen augment peripheral nerve regeneration. Neurochem Res. 2009;34:1304–16.
Lavasani M, Thompson SD, Pollett JB, Usas A, Lu A, Stolz DB, et al. Human muscle–derived stem/progenitor cells promote functional murine peripheral nerve regeneration. J Clin Investig. 2014;124:1745–56.
Van der Velden J, Snibson KJ. Airway disease: the use of large animal models for drug discovery. Pulm Pharmacol Ther. 2011;24:525–32.
IJkema-Paassen J, Jansen K, Gramsbergen A, Meek M. Transection of peripheral nerves, bridging strategies and effect evaluation. Biomaterials. 2004;25:1583–92.
Dolenc V, Janko M. Nerve regeneration following primary repair. Acta Neurochir. 1976;34:223–34.
Allen MJ, Leone KA, Lamonte K, Townsend KL, Mann KA. Cemented total knee replacement in 24 dogs: surgical technique, clinical results, and complications. Vet Surg. 2009;38:555–67.
Hesbach AL. Techniques for objective outcome assessment. Clin Tech Small Anim Pract. 2007;22:146–54.
Council, N.R., Chimpanzees in biomedical and behavioral research: assessing the necessity. 2011.
Angius D, Wang H, Spinner RJ, Gutierrez-Cotto Y, Yaszemski MJ, Windebank AJ. A systematic review of animal models used to study nerve regeneration in tissue-engineered scaffolds. Biomaterials. 2012;33:8034–9.
Wadman M. Chimp research under scrutiny. Nature. 2011;480:424–5.
Hea Gu J, Hwa Ji Y, Dhong ES, Hwee Kim D, Yoon ES. Transplantation of adipose derived stem cells for peripheral nerve regeneration in sciatic nerve defects of the rat. Curr Stem Cell Res Ther. 2012;7:347–55.
Carriel V, Garrido-Gómez J, Hernández-Cortés P, Garzón I, García-García S, Sáez-Moreno JA, et al. Combination of fibrin-agarose hydrogels and adipose-derived mesenchymal stem cells for peripheral nerve regeneration. J Neural Eng. 2013;10: 026022.
Schaakxs D, Kalbermatten DF, Pralong E, Raffoul W, Wiberg M, Kingham PJ. Poly-3-hydroxybutyrate strips seeded with regenerative cells are effective promoters of peripheral nerve repair. J Tissue Eng Regen Med. 2017;11:812–21.
Saller MM, Huettl RE, Mayer JM, Feuchtinger A, Krug C, Holzbach T, et al. Validation of a novel animal model for sciatic nerve repair with an adipose-derived stem cell loaded fibrin conduit. Neural Regen Res. 2018;13:854.
Fu XM, Wang Y, Fu Wl, Liu DH, Zhang CY, Wang QL, et al. The combination of adipose-derived schwann-like cells and acellular nerve allografts promotes sciatic nerve regeneration and repair through the JAK2/STAT3 signaling pathway in rats. Neuroscience. 2019;422:134–45.
Soto PA, Vence M, Piñero GM, Coral DF, Usach V, Muraca D, et al. Sciatic nerve regeneration after traumatic injury using magnetic targeted adipose-derived mesenchymal stem cells. Acta Biomater. 2021;130:234–47.
Lasso J, Cano RP, Castro Y, Arenas L, García J, Fernández-Santos M. Xenotransplantation of human adipose-derived stem cells in the regeneration of a rabbit peripheral nerve. J Plast Reconstr Aesthet Surg. 2015;68:e189–97.
Pedroza-Montoya FE, Tamez-Mata YA ,Simental-Mendía M, Soto-Domínguez A, García-Pérez MM, Said-Fernández S, et al. Repair of ovine peripheral nerve injuries with xenogeneic human acellular sciatic nerves prerecellularized with allogeneic Schwann-like cells—an innovative and promising approach. Regenerat Therapy. 2022;19:131–43.
Cuevas P, Carceller F, Dujovny M, Garcia-Gómez I, Cuevas BA, González-Corrochano R, et al. Peripheral nerve regeneration by bone marrow stromal cells. Neurol Res. 2002;24:634–8.
Chen CJ, Ou YC, Liao SL, Chen WY, Chen SY, Wu CW, et al. Transplantation of bone marrow stromal cells for peripheral nerve repair. Exp Neurol. 2007;204:443–53.
Abd El Samad AA, Raafat MH, Shokry Y, Zahra FAA, Abdellah AM. Histological study on the role of bone marrow-derived mesenchymal stem cells on the sciatic nerve and the gastrocnemius muscle in a model of sciatic nerve crush injury in albino rats. Egypt J Histol. 2015;38:438–51.
Yao M, Zhou Y, Xue C, Ren H, Wang S, Zhu H, et al. Repair of rat sciatic nerve defects by using allogeneic bone marrow mononuclear cells combined with chitosan/silk fibroin scaffold. Cell Transplant. 2016;25:983–93.
Weiss JB, Phillips CJ, Malin EW, Gorantla VS, Harding JW, Salgar SK. Stem cell, granulocyte-colony stimulating factor and/or dihexa to promote limb function recovery in a rat sciatic nerve damage-repair model: experimental animal studies. Ann Med Surg. 2021;71: 102917.
Guo M, Li D, Wu L, Li M, Yang B. Bone marrow mesenchymal stem cells repair brachial plexus injury in rabbits through ERK pathway. Eur Rev Med Pharmacol Sci. 2020;24:1515–23.
Ding F, Wu J, Yang Y, Hu W, Zhu Q, Tang X, et al. Use of tissue-engineered nerve grafts consisting of a chitosan/poly (lactic-co-glycolic acid)-based scaffold included with bone marrow mesenchymal cells for bridging 50-mm dog sciatic nerve gaps. Tissue Eng Part A. 2010;16:3779–90.
Xue C, Zhu H, Tan D, Ren H, Gu X, Zhao Y, et al. Electrospun silk fibroin-based neural scaffold for bridging a long sciatic nerve gap in dogs. J Tissue Eng Regen Med. 2018;12:e1143–53.
Wang D, Liu XL, Zhu JK, Jiang L, Hu J, Zhang Y, et al. Bridging small-gap peripheral nerve defects using acellular nerve allograft implanted with autologous bone marrow stromal cells in primates. Brain Res. 2008;1188:44–53.
Hu N, Wu H, Xue C, Gong Y, Wu J, Xiao Z, et al. Long-term outcome of the repair of 50 mm long median nerve defects in rhesus monkeys with marrow mesenchymal stem cells-containing, chitosan-based tissue engineered nerve grafts. Biomaterials. 2013;34:100–11.
Cruz Villagrán C, Schumacher J, Donnell R, Dhar MS. A novel model for acute peripheral nerve injury in the horse and evaluation of the effect of mesenchymal stromal cells applied in situ on nerve regeneration: a preliminary study. Front Veterinary Sci. 2016;3:80.
Gärtner A, Pereira T, Armada-da-Silva P, Amorim I, Gomes R, Ribeiro J, et al. Use of poly (DL-lactide-ε-caprolactone) membranes and mesenchymal stem cells from the Wharton’s jelly of the umbilical cord for promoting nerve regeneration in axonotmesis: in vitro and in vivo analysis. Differentiation. 2012;84:355–65.
Sung MA, Jung HJ, Lee JW, Lee JY, Pang KM, Yoo SB, et al. Human umbilical cord blood-derived mesenchymal stem cells promote regeneration of crush-injured rat sciatic nerves. Neural Regen Res. 2012;7:2018.
Xia N, Xu JM, Zhao N, Zhao QS, Li M, Cheng ZF. Human mesenchymal stem cells improve the neurodegeneration of femoral nerve in a diabetic foot ulceration rats. Neurosci Lett. 2015;597:84–9.
Hei Wh, Almansoori AA, Sung MA, Ju KW, Seo N, Lee SH, et al. Adenovirus vector-mediated ex vivo gene transfer of brain-derived neurotrophic factor (BDNF) tohuman umbilical cord blood-derived mesenchymal stem cells (UCB-MSCs) promotescrush-injured rat sciatic nerve regeneration. Neurosci Lett. 2017;643:111–20.
Ma Y, Dong L, Zhou D, Li L, Zhang W, Zhen Y, et al. Extracellular vesicles from human umbilical cord mesenchymal stem cells improve nerve regeneration after sciatic nerve transection in rats. J Cell Mol Med. 2019;23:2822–35.
Xiao Q, Zhang X, Wu Y. Experimental research on differentiation-inducing growth of nerve lateral bud by HUC-MSCs chitosan composite conduit. Cell Biochem Biophys. 2015;73:305–11.
Cui Y, Yao Y, Zhao Y, Xiao Z, Cao Z, Han S, et al. Functional collagen conduits combined with human mesenchymal stem cells promote regeneration after sciatic nerve transection in dogs. J Tissue Eng Regen Med. 2018;12:1285–96.
Al-Zaidi AA, Al-Timmemi HA, Shabeeb ZA. Efficacy of acellular-lyophilized human umbilical cord ecm-powder guided by bovine urinary bladder matrix conduit for peripheral nerve repair in dogs modEL. Plant Archiv. 2021;21(1):456–63.
Pan HC, Yang DY, Chiu YT, Lai SZ, Wang YC, Chang MH, et al. Enhanced regeneration in injured sciatic nerve by human amniotic mesenchymal stem cell. J Clin Neurosci. 2006;13:570–5.
Tsai M, Pan H, Liou D, Weng C, Hoffer BJ, Cheng H. Adenoviral gene transfer of bone morphogenetic protein-7 enhances functional recovery after sciatic nerve injury in rats. Gene Ther. 2010;17:1214–24.
Lin YC, Ramadan M, Van Dyke M, Kokai LE, Philips BJ, Rubin JP, et al. Keratin gel filler for peripheral nerve repair in a rodent sciatic nerve injury model. Plast Reconstr Surg. 2012;129:67–78.
Ni HC, Tseng TC, Chen JR, Hsu Sh, Chiu IM. Fabrication of bioactive conduits containing the fibroblast growth factor 1 and neural stem cells for peripheral nerve regeneration across a 15 mm critical gap. Biofabrication. 2013;5:035010.
Zarbakhsh S, Goudarzi N, Shirmohammadi M, Safari M. Histological study of bone marrow and umbilical cord stromal cell transplantation in regenerating rat peripheral nerve. Cell J (Yakhteh). 2016;17:668.
Labroo P, Shea J, Edwards K, Ho S, Davis B, Sant H, et al. Novel drug delivering conduit for peripheral nerve regeneration. J Neural Eng. 2017;14: 066011.
Wang C, Jia Y, Yang W, Zhang C, Zhang K, Chai Y. Silk fibroin enhances peripheral nerve regeneration by improving vascularization within nerve conduits. J Biomed Mater Res, Part A. 2018;106:2070–7.
McKenzie IA, Biernaskie J, Toma JG, Midha R, Miller FD. Skin-derived precursors generate myelinating Schwann cells for the injured and dysmyelinated nervous system. J Neurosci. 2006;26:6651–60.
Magown P, Rafuse VF, Brownstone RM. Microcircuit formation following transplantation of mouse embryonic stem cell-derived neurons in peripheral nerve. J Neurophysiol. 2017;117:1683–9.
Lee DC, Chen JH, Hsu TY, Chang LH, Chang H, Chi YH, et al. Neural stem cells promote nerve regeneration through IL12-induced Schwann cell differentiation. Mol Cell Neurosci. 2017;79:1–11.
Mozafari R, Kyrylenko S, Castro MV, Ferreira Jr RS, Barraviera B, Oliveira ALR. Combination of heterologous fibrin sealant and bioengineered human embryonic stem cells to improve regeneration following autogenous sciatic nerve grafting repair. J Venom Anim Toxins Incl Trop Dis. 2018;24:11.
Strauch B, Rodriguez DM, Diaz J, Yu H-L, Kaplan G, Weinstein DE. Autologous Schwann cells drive regeneration through a 6-cm autogenous venous nerve conduit. J Reconstr Microsurg. 2001;17:589–98.
Zhu Y, Peng N, Wang J, Jin Z, Zhu L, Wang Y, et al. Peripheral nerve defects repaired with autogenous vein grafts filled with platelet-rich plasma and active nerve microtissues and evaluated by novel multimodal ultrasound techniques. Biomater Res. 2022;26:1–29.
Brenner MJ, Lowe JB, Fox IK, Mackinnon SE, Hunter DA, Darcy MD, et al. Effects of Schwann cells and donor antigen on long-nerve allograft regeneration. Microsurg Official J Int Microsurg Soc Eur Fed Soc Microsurg. 2005;25:61–70.
Su CF, Chang LH, Kao CY, Lee DC, Cho KH, Kuo LW, et al. Application of amniotic fluid stem cells in repairing sciatic nerve injury in minipigs. Brain Res. 2018;1678:397–406.
Hu J, Zhu Q-T, Liu X-L, Xu Y-b, Zhu J-K. Repair of extended peripheral nerve lesions in rhesus monkeys using acellular allogenic nerve grafts implanted with autologous mesenchymal stem cells. Exp Neurol. 2007;204:658–66.
Saheb-Al-Zamani M, Yan Y, Farber SJ, Hunter DA, Newton P, Wood MD, et al. Limited regeneration in long acellular nerve allografts is associated with increased Schwann cell senescence. Exp Neurol. 2013;247:165–77.
Ruini F, Tonda-Turo C, Raimondo S, Tos P, Pugliese P, Geuna S, et al. Nerve guidance conduits based on bi-layer chitosan membranes for peripheral nerve regeneration. Biomedical Science and Engineering, 2016;1:1.
Fregnan F, Ciglieri E, Tos P, Crosio A, Ciardelli G, Ruini F, et al. Chitosan crosslinked flat scaffolds for peripheral nerve regeneration. Biomed Mater. 2016;11: 045010.
Pixley SK, Hopkins TM, Little KJ, Hom DB. Evaluation of peripheral nerve regeneration through biomaterial conduits via micro-CT imaging. Laryngoscope Invest Otolaryngol. 2016;1:185–90.
Zhu L, Wang K, Ma T, Huang L, Xia B, Zhu S, et al. Noncovalent bonding of RGD and YIGSR to an electrospun poly (ε-caprolactone) conduit through peptide self-assembly to synergistically promote sciatic nerve regeneration in rats. Adv Healthcare Mater. 2017;6:1600860.
Tao J, Hu Y, Wang S, Zhang J, Liu X, Gou Z, et al. A 3D-engineered porous conduit for peripheral nerve repair. Sci Rep. 2017;7:1–13.
Yapici AK, Bayram Y, Akgun H, Gumus R, Zor F. The effect of in vivo created vascularized neurotube on peripheric nerve regeneration. Injury. 2017;48:1486–91.
Stocco E, Barbon S, Lora L, Grandi F, Sartore L, Tiengo C, et al. Partially oxidized polyvinyl alcohol conduitfor peripheral nerve regeneration. Sci Rep. 2018;8:1–14.
Yin K, Divakar P, Hong J, Moodie KL, Rosen JM, Sundback CA, et al. Freeze-cast porous chitosan conduit for peripheral nerve repair. MRS Adv. 2018;3:1677–83.
Lin KM, Shea J, Gale BK, Sant H, Larrabee P, Agarwal J. Nerve growth factor released from a novel PLGA nerve conduit can improve axon growth. J Micromech Microeng. 2016;26: 045016.
Strauch B, Ferder M, Lovelle-Allen S, Moore K, Kim D, Llena J. Determining the maximal length of a vein conduit used as an interposition graft for nerve regeneration. J Reconstr Microsurg. 1996;12:521–7.
Koller R, Rab M, Todoroff B, Neumayer C, Haslik W, Sto H, et al. The influence of the graft length on the functional and morphological result after nerve grafting: an experimental study in rabbits. Br J Plast Surg. 1997;50:609–14.
Chang YC, Chen MH, Liao SY, Wu HC, Kuan CH, Sun JS, et al. Multichanneled nerve guidance conduit with spatial gradients of neurotrophic factors and oriented nanotopography for repairing the peripheral nervous system. ACS Appl Mater Interfaces. 2017;9:37623–36.
Pover CM, Lisney S. Influence of autograft size on peripheral nerve regeneration in cats. J Neurol Sci. 1989;90:179–85.
Sufan W, Suzuki Y, Tanihara M, Ohnishi K, Suzuki K, Endo K, et al. Sciatic nerve regeneration through alginate with tubulation or nontubulation repair in cat. J Neurotrauma. 2001;18:329–38.
Matsumoto K, Ohnishi K, Kiyotani T, Sekine T, Ueda H, Nakamura T, et al. Peripheral nerve regeneration across an 80-mm gap bridged by a polyglycolic acid (PGA)–collagen tube filled with laminin-coated collagen fibers: a histological and electrophysiological evaluation of regenerated nerves. Brain Res. 2000;868:315–28.
Wang X, Hu W, Cao Y, Yao J, Wu J, Gu X. Dog sciatic nerve regeneration across a 30-mm defect bridged by a chitosan/PGA artificial nerve graft. Brain. 2005;128:1897–910.
Yao Y, Cui Y, Zhao Y, Xiao Z, Li X, Han S, et al. Efect of longitudinally oriented collagen conduit combined with nerve growth factor on nerve regeneration after dog sciatic nerve injury. J Biomed Mater Res B Appl Biomater. 2018;106:2131–9.
Archibald S, Shefner J, Krarup C, Madison R. Monkey median nerve repaired by nerve graft or collagen nerve guide tube. J Neurosci. 1995;15:4109–23.
Matsuyama T, Midha R, Mackinnon SE, Munro CA, Wong P-Y, Ang LC. Long nerve allografts in sheep with cyclosporin A immunosuppression. J Reconstr Microsurg. 2000;16:0219–26.
Radtke C, Allmeling C, Waldmann K-H, Reimers K, Thies K, Schenk HC, et al. Spider silk constructs enhance axonal regeneration and remyelination in long nerve defects in sheep. PLoS One. 2011;6: e16990.
D. Alvites R, V. Branquinho M, Sousa AC, Zen F, Maurina M, Raimondo S, et al. Establishment of a sheep model for hind limb peripheral nerve injury: common peroneal nerve. Int J Mol Sci. 2021;22:1401.
Algora J, Chen LE, Seaber AV, Wong GH, Urbaniak JR. Functional effects of lymphotoxin on crushed peripheral nerve. Microsurg Official J Int Microsurg Soc Eur Federation Soc Microsurg. 1996;17:131–5.
Muthuraman A, Diwan V, Jaggi AS, Singh N, Singh D. Ameliorative effects of Ocimum sanctum in sciatic nerve transection-induced neuropathy in rats. J Ethnopharmacol. 2008;120:56–62.
Kalender AM, Dogan A, Bakan V, Yildiz H, Gokalp MA, Kalender M. Effect of Zofenopril on regeneration of sciatic nerve crush injury in a rat model. J Brachial Plexus Peripheral Nerve Injury. 2009;4:e29–35.
Senoglu M, Nacitarhan V, Kurutas EB, Senoglu N, Altun I, Atli Y, et al. Intraperitoneal Alpha-Lipoic Acid to prevent neural damage after crush injury to the rat sciatic nerve. J Brachial Plexus Peripheral Nerve Injury. 2009;4:e109–14.
Yüce S, Gökçe EC, Iskdemir A, Koç ER, Cemil DB, Gökçe A, et al. An experimental comparison of the effects of propolis, curcumin, and methylprednisolone on crush injuries of the sciatic nerve. Ann Plast Surg. 2015;74:684–92.
Feng X, Yuan W. Dexamethasone enhanced functional recovery after sciatic nerve crush injury in rats. BioMed Res Int. 2015;2015:1–9.
Korkmaz MF, Ceylan MF, Parlakpinar H, Sağir M, Levent E, Şamdanci E, et al. The effect of sildenafil on recuperation from sciatic nerve injury in rats. Balkan Med J. 2016;33:204–11.
Nobakhti-Afshar A, Najafpour A, Mohammadi R, Zarei L. Assessment of neuroprotective effects of local administration of 17-beta-estradiol on peripheral nerve regeneration in ovariectomized female rats. Bull Emergency Trauma. 2016;4:141.
Rosa Junior GM, Magalhães RMG, Rosa VC, Bueno CRdS, Simionato LH, Bortoluci CHF. Effect of the laser therapy in association with swimming for a morphological nerve repair and functional recovery in rats submitted to sciatic axonotmesis. Fisioterapia e Pesquisa. 2016;23:12–20.
Farjah GH, Dolatkhah MA, Pourheidar B, Heshmatian B. The effect of cerebro-spinal fluid in collagen guide channel on sciatic nerve regeneration in rat. Turk Neurosurg. 2017;27:453–9.
Suzuki K, Tanaka H, Ebara M, Uto K, Matsuoka H, Nishimoto S, et al. Electrospun nanofiber sheets incorporating methylcobalamin promote nerve regeneration and functional recovery in a rat sciatic nerve crush injury model. Acta Biomater. 2017;53:250–9.
Ni XJ, Wang XD, Zhao YH, Sun HL, Hu YM, Yao J, et al. The effect of low-intensity ultrasound on brain-derived neurotropic factor expression in a rat sciatic nerve crushed injury model. Ultrasound Med Biol. 2017;43:461–8.
Özbek Z, Aydin H, Kocman A, Ozkara E, Şahin E, Bektur E, et al. Neuroprotective effect of genistein in peripheral nerve injury. Turkish Neurosurg. 2017;27:816-22.
Guo Q, Liu C, Hai B, Ma T, Zhang W, Tan J, et al. Chitosan conduits filled with simvastatin/Pluronic F-127 hydrogel promote peripheral nerve regeneration in rats. J Biomed Mater Res B Appl Biomater. 2018;106:787–99.
Gan L, Qian M, Shi K, Chen G, Gu Y, Du W, et al. Restorative effect and mechanism of mecobalamin on sciatic nerve crush injury in mice. Neural Regen Res. 2014;9:1979.
Jensen JN, Brenner MJ, Tung TH, Hunter DA, Mackinnon SE. Effect of FK506 on peripheral nerve regeneration through long grafts in inbred swine. Ann Plast Surg. 2005;54:420–7.
Acknowledgement
Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB). The authors’ research incorporated in this article did not obtain any particular grant from funding organizations in the public, or not-for-profit sectors.
Author information
Authors and Affiliations
Contributions
E-BSH and AAI created the idea for the article. E-BSH, AAI, KMM, and IAM designed the research work, collected the review data, and revised the manuscript draft. E-SMA designed the charts included in the review and all authors reviewed and approved the last version of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
There are no conflicts of interest to declare.
Ethical statement
There are no animals experiments carried out for this article.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Khaled, M.M., Ibrahium, A.M., Abdelgalil, A.I. et al. Regenerative Strategies in Treatment of Peripheral Nerve Injuries in Different Animal Models. Tissue Eng Regen Med 20, 839–877 (2023). https://doi.org/10.1007/s13770-023-00559-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13770-023-00559-4